Activaero Report issue

For profit Phase 2
Founded: Gemunden Germany (2004)
Status: Acquired by Vectura (2014) → now Carlyle Group (2021)

Organization Overview

First Clinical Trial
2010
NCT01200108
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Activaero GmbH | Peter Kardos

Active Ingredients

Drugs in Phase 2 Trials (1)

budesonide (rhinocort) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1